Masimo Co. (NASDAQ:MASI) shares hit a new 52-week high during mid-day trading on Friday . The company traded as high as $110.72 and last traded at $110.15, with a volume of 15446 shares traded. The stock had previously closed at $109.40.

A number of research analysts have recently issued reports on MASI shares. ValuEngine downgraded shares of Masimo from a “buy” rating to a “hold” rating in a research report on Thursday, June 7th. Zacks Investment Research downgraded shares of Masimo from a “buy” rating to a “hold” rating in a research report on Monday, May 7th. BidaskClub raised shares of Masimo from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, May 8th. Piper Jaffray Companies lifted their price objective on shares of Masimo to $94.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 2nd. Finally, Stifel Nicolaus lifted their price objective on shares of Masimo from $108.00 to $112.00 and gave the stock a “buy” rating in a research report on Thursday, August 2nd. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $102.60.

The stock has a market capitalization of $5.65 billion, a PE ratio of 44.75, a P/E/G ratio of 2.55 and a beta of 0.89.

Masimo (NASDAQ:MASI) last issued its quarterly earnings data on Wednesday, August 1st. The medical equipment provider reported $0.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.02. The firm had revenue of $211.62 million for the quarter, compared to the consensus estimate of $207.85 million. Masimo had a net margin of 15.30% and a return on equity of 21.49%. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.83 EPS. equities research analysts expect that Masimo Co. will post 2.9 EPS for the current year.

In other Masimo news, CEO Joe E. Kiani sold 29,273 shares of the business’s stock in a transaction that occurred on Thursday, August 2nd. The shares were sold at an average price of $109.08, for a total transaction of $3,193,098.84. Following the sale, the chief executive officer now owns 168,514 shares of the company’s stock, valued at approximately $18,381,507.12. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CAO Ramshorst David J. Van sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 30th. The stock was sold at an average price of $100.00, for a total transaction of $300,000.00. Following the sale, the chief accounting officer now directly owns 4,000 shares in the company, valued at approximately $400,000. The disclosure for this sale can be found here. In the last three months, insiders have sold 108,347 shares of company stock worth $11,646,589. 12.60% of the stock is owned by insiders.

Large investors have recently added to or reduced their stakes in the business. Eaton Vance Management grew its position in Masimo by 160.2% during the 1st quarter. Eaton Vance Management now owns 84,311 shares of the medical equipment provider’s stock worth $7,415,000 after purchasing an additional 51,911 shares during the last quarter. Tributary Capital Management LLC grew its position in Masimo by 9.7% during the 2nd quarter. Tributary Capital Management LLC now owns 151,085 shares of the medical equipment provider’s stock worth $14,753,000 after purchasing an additional 13,300 shares during the last quarter. Swiss National Bank grew its position in Masimo by 2.1% during the 1st quarter. Swiss National Bank now owns 85,900 shares of the medical equipment provider’s stock worth $7,555,000 after purchasing an additional 1,800 shares during the last quarter. BlackRock Inc. grew its position in Masimo by 0.7% during the 1st quarter. BlackRock Inc. now owns 7,301,352 shares of the medical equipment provider’s stock worth $642,154,000 after purchasing an additional 53,887 shares during the last quarter. Finally, Hsbc Holdings PLC grew its position in Masimo by 1,149.6% during the 1st quarter. Hsbc Holdings PLC now owns 40,137 shares of the medical equipment provider’s stock worth $3,530,000 after purchasing an additional 36,925 shares during the last quarter. 83.57% of the stock is currently owned by institutional investors.

Masimo Company Profile

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

See Also: Price to Earnings Ratio (PE), For Valuing Stocks

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.